Corrigendum to “ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling” [Biomed. Pharmacother. 193 (2025) 118884]

Biomedicine & Pharmacotherapy 2026 Open access

Read full text
Authors: Nareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, Nithi Asavapanumas, Sarun Rangketkarn, Umnuaychoke Thongsa-ad, Waraluck Chaichompoo, Apichart Suksamrarn, Sunhapas Soodvilai, Duangrat Tantikanlayaporn
DOI: 10.1016/j.biopha.2026.119030
Cited by: 0

Fields of Study & Subjects

Mesenchymal stem cell research Curcumin's Biomedical Applications Bone Metabolism and Diseases

Publication details

Journal / source
Biomedicine & Pharmacotherapy
Volume
196
Pages
119030–119030
Publication date
31 January 2026
Language
EN